Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Elevated serum progastrin‐releasing peptide (31–98) in metastatic and androgen‐independent prostate cancer patients *
- M. Yashi, O. Muraishi, Y. Kobayashi, A. Tokue, H. Nanjo
- Medicine
- The Prostate
- 1 May 2002
Increases in neuroendocrine phenotype and secretory products are closely correlated with tumor progression and androgen independence in prostate cancer. In this study, we explored this correlation… Expand
Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma
- Hironori Betsunoh, Takehiko Fukuda, +10 authors T. Kamai
- Biology, Medicine
- BMC Cancer
- 30 October 2013
BackgroundThe system L amino acid transporter (LAT) has an important role in the transport of various amino acids, and there have been reports about the relation of this system to cancer. Although… Expand
Anteroposterior dissection HoLEP: a modification to prevent transient stress urinary incontinence.
- F. Endo, Y. Shiga, +5 authors O. Muraishi
- Medicine
- Urology
- 1 December 2010
OBJECTIVES
The prevalence of transient stress urinary incontinence (SUI) after HoLEP has been reported to be as high as 44%. Anteroposterior dissection HoLEP was newly developed to protect the… Expand
Kidney transplantation of living unrelated donor-recipient combinations.
- N. Ishikawa, T. Yagisawa, +4 authors M. Yashi
- Medicine
- Transplantation proceedings
- 2012
INTRODUCTION
According to the Japanese renal transplant registry in 2009, there were 1123 living kidney transplantations (LKT), including 35% from spouses (husband/wife). Up to the present in Japan,… Expand
Tumor infiltrating dendritic cells predict treatment response to immmunotherapy in patients with metastatic renal cell carcinoma.
- M. Kobayashi, K. Suzuki, M. Yashi, M. Yuzawa, N. Takayashiki, T. Morita
- Medicine
- Anticancer research
- 1 March 2007
BACKGROUND
Although renal cell carcinoma (RCC) is considered to be an immunogenic tumor, the role of immunogenicity in this tumor for predicting treatment response has been little investigated.
… Expand
Metronomic oral cyclophosphamide chemotherapy possibly contributes to stabilization of disease in patients with metastatic castration-resistant prostate cancer: a prospective analysis of consecutive…
- M. Yashi, Daisaku Nishihara, +8 authors T. Kamai
- Medicine
- Clinical genitourinary cancer
- 1 October 2014
INTRODUCTION/BACKGROUND
Castration-resistant prostate cancer remains a therapeutic challenge, even after establishing the survival benefits of docetaxel chemotherapy. Metronomic chemotherapy… Expand
Retroperitoneoscopic hand-assisted live-donor nephrectomy according to the basic principle of transplantation in donor kidney selection.
- M. Yashi, T. Yagisawa, N. Ishikawa, A. Nukui, T. Fujiwara, Y. Sakuma
- Medicine
- Journal of endourology
- 16 July 2007
PURPOSE
We assessed the feasibility of retroperitoneoscopic hand-assisted live-donor nephrectomy according to the basic principle of transplantation in kidney selection, namely, leaving the… Expand
Transplantation of ABO-incompatible and living unrelated donor-recipient combinations.
- N. Ishikawa, T. Yagisawa, +4 authors N. Miyamoto
- Medicine
- Transplantation proceedings
- 1 September 2008
INTRODUCTION
According to the Japanese renal transplant registry 2005, 834 transplantations were performed using living donors. Among them 199 (23.9%) kidneys were donated from spouses (husband/wife)… Expand
Opening the bladder for cesarean hysterectomy for placenta previa percreta with bladder invasion
- S. Matsubara, A. Ohkuchi, +7 authors Mitsuaki Suzuki
- Medicine
- The journal of obstetrics and gynaecology…
- 1 April 2009
Cesarean hysterectomy for placenta previa percreta with bladder invasion often induces not only massive hemorrhage but also severe bladder/ureter injuries. A 37‐year‐old woman with previous cesarean… Expand
The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells
- Hideyuki Abe, T. Kamai, +10 authors K. Yoshida
- Medicine
- BMC Cancer
- 7 June 2014
BackgroundActivation of Rho, one of the small GTPases, and its major downstream target Rho-kinase (ROCK) promotes the development and metastasis of cancer. We previously showed that elevation of Rho… Expand